NASDAQ:XRAY - DENTSPLY SIRONA Stock Price, Forecast & News

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

DENTSPLY SIRONA announced a quarterly dividend on Friday, December 13th. Stockholders of record on Friday, December 27th will be paid a dividend of $0.10 per share on Friday, January 10th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.66%. The ex-dividend date of this dividend is Thursday, December 26th. View DENTSPLY SIRONA's Dividend History.

DENTSPLY SIRONA Inc (NASDAQ:XRAY) announced its earnings results on Thursday, November, 7th. The medical instruments supplier reported $0.57 earnings per share for the quarter, topping analysts' consensus estimates of $0.50 by $0.07. The medical instruments supplier earned $962.10 million during the quarter, compared to analyst estimates of $940.38 million. DENTSPLY SIRONA had a return on equity of 10.08% and a net margin of 4.08%. DENTSPLY SIRONA's quarterly revenue was up 3.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.38 earnings per share. View DENTSPLY SIRONA's Earnings History.

DENTSPLY SIRONA is scheduled to release their next quarterly earnings announcement on Friday, March 6th 2020. View Earnings Estimates for DENTSPLY SIRONA.

DENTSPLY SIRONA issued an update on its FY19 earnings guidance on Thursday, November, 7th. The company provided EPS guidance of $2.42-2.48 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.39. The company issued revenue guidance of $3.95-4.05 billion, compared to the consensus revenue estimate of $3.99 billion.

10 equities research analysts have issued 12-month price targets for DENTSPLY SIRONA's shares. Their forecasts range from $50.00 to $65.00. On average, they expect DENTSPLY SIRONA's stock price to reach $58.08 in the next twelve months. This suggests that the stock has a possible downside of 4.3%. View Analyst Price Targets for DENTSPLY SIRONA.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 7 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for DENTSPLY SIRONA.

News stories about XRAY stock have trended neutral on Wednesday, InfoTrie reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. DENTSPLY SIRONA earned a news sentiment score of 0.5 on InfoTrie's scale. They also gave media stories about the medical instruments supplier a news buzz of 2.0 out of 10, indicating that recent news coverage is very unlikely to have an impact on the stock's share price in the immediate future. View News Stories for DENTSPLY SIRONA.

DENTSPLY SIRONA saw a decline in short interest in the month of December. As of December 31st, there was short interest totalling 3,540,000 shares, a decline of 17.1% from the December 15th total of 4,270,000 shares. Based on an average trading volume of 1,320,000 shares, the short-interest ratio is currently 2.7 days. Currently, 1.6% of the shares of the stock are short sold. View DENTSPLY SIRONA's Current Options Chain.

Some companies that are related to DENTSPLY SIRONA include Align Technology (ALGN), Cooper Companies (COO), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Antares Pharma (ATRS), Anika Therapeutics (ANIK), Cerus (CERS), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include Gilead Sciences (GILD), NVIDIA (NVDA), QUALCOMM (QCOM), Starbucks (SBUX), Amgen (AMGN), Costco Wholesale (COST), Intel (INTC), Boeing (BA), General Electric (GE) and Analog Devices (ADI).

DENTSPLY SIRONA's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (0.24%), Candriam Luxembourg S.C.A. (0.24%), Commerzbank Aktiengesellschaft FI (0.09%), State of Alaska Department of Revenue (0.06%), Tocqueville Asset Management L.P. (0.05%) and Clean Yield Group (0.05%). Company insiders that own DENTSPLY SIRONA stock include Betsy D Holden, Daniel P Key, Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Markus Boehringer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman, Nicholas W Alexos and William E Newell. View Institutional Ownership Trends for DENTSPLY SIRONA.

XRAY stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Clean Yield Group, IFM Investors Pty Ltd, M&R Capital Management Inc., Welch & Forbes LLC, Tributary Capital Management LLC and CENTRAL TRUST Co. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Eric Brandt, Markus Boehringer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman and William E Newell. View Insider Buying and Selling for DENTSPLY SIRONA.

XRAY stock was bought by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., Tocqueville Asset Management L.P., Cardinal Capital Management, Boston Trust Walden Corp, Bowling Portfolio Management LLC, State of Alaska Department of Revenue, Assenagon Asset Management S.A. and Commerzbank Aktiengesellschaft FI. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Betsy D Holden, Daniel P Key, Donald M Jr Casey, Gregory T Lucier and Nicholas W Alexos. View Insider Buying and Selling for DENTSPLY SIRONA.

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of XRAY stock can currently be purchased for approximately $60.71.

DENTSPLY SIRONA has a market capitalization of $13.50 billion and generates $3.99 billion in revenue each year. The medical instruments supplier earns $-1,011,000,000.00 in net income (profit) each year or $2.01 on an earnings per share basis. DENTSPLY SIRONA employs 16,400 workers across the globe.View Additional Information About DENTSPLY SIRONA.

The official website for DENTSPLY SIRONA is http://www.dentsplysirona.com/.

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at 844-546-3722 or via email at [email protected]